K. Resnick

发表

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.

Hansjuerg Alder, C. Croce, H. Alder, 2009, Gynecologic oncology.

Robotic Trocar Site Small Bowel Evisceration After Gynecologic Cancer Surgery

D. Cohn, F. Backes, L. Seamon, 2008, Obstetrics and gynecology.

Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance

A. Difeo, S. Waggoner, P. Joseph, 2015, Oncotarget.

Small-Molecule–Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death

Dafydd G. Thomas, A. Difeo, G. Narla, 2022, bioRxiv.

Patterns of First Recurrence in African American Patients with High Grade Epithelial Ovarian Carcinoma

K. Resnick, Sareena Singh, A. Armstrong, 2015, Gynecologic and Obstetric Investigation.

Lynch Syndrome Screening Strategies Among Newly Diagnosed Endometrial Cancer Patients

H. Hampel, D. Cohn, F. Backes, 2009, Obstetrics and gynecology.

Lynch Syndrome and Endometrial Cancer

K. Resnick, Sareena Singh, 2017, Southern medical journal.

Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.

S. Waggoner, A. Dowlati, T. Radivoyevitch, 2013, Gynecologic oncology.

Preoperative predictors of delay in initiation of adjuvant chemotherapy in patients undergoing primary debulking surgery for ovarian cancer.

K. Resnick, Sareena Singh, Megan Guetzko, 2016, Gynecologic oncology.

Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study

E. Jenison, P. Goodfellow, S. Waggoner, 2021, JCO precision oncology.

The Prognostic Value of Baseline Lymphocyte, Neutrophil, and Monocyte Counts in Locally Advanced Cervical Carcinoma Treated with Radiation

C. Nagel, J. Himler, K. Resnick, 2017, Obstetrics and gynecology international.

At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysis.

D. Cohn, J. Straughn, D. O’Malley, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated groin recurrence of vulvar cancer salvaged with multimodality therapy.

J. Fowler, Douglas D. Martin, D. Richardson, 2009, Gynecologic oncology.

Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer.

D. Cohn, J. Fowler, L. Copeland, 2006, Gynecologic oncology.

Non-Hodgkin's lymphoma mimicking gynecological malignancies of the vagina and cervix: a report of four cases

V. Zanagnolo, D. Cohn, L. Eaton, 2006, International Journal of Gynecologic Cancer.

Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.

B. Ramaswamy, C. Shapiro, Xin Wu, 2013, Translational research : the journal of laboratory and clinical medicine.

The highly recurrent PP2A Aα-subunit mutation P179R alters protein structure and impairs PP2A enzyme function to promote endometrial tumorigenesis.

A. Difeo, G. Narla, M. Jackson, 2019, Cancer research.

A multi-institutional review of outcomes of endometrial stromal sarcoma.

D. Mutch, P. Argenta, M. Geller, 2007, Gynecologic oncology.

Comprehensive miRNA profiling of surgically staged endometrial cancer.

Muller Fabbri, Nicola Valeri, Hansjuerg Alder, 2010, American journal of obstetrics and gynecology.

Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.

R. Fishel, H. Hampel, D. Cohn, 2009, Gynecologic oncology.

Ovarian and Endometrial Cancer in Patients with Hereditary Non-polyposis Colorectal Cancer Syndrome

D. Cohn, K. Resnick, 2009 .

Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation.

P. Crilley, D. Marks, E. Bernstein, 1995, Bone marrow transplantation.

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)

D. Mutch, P. Fracasso, P. Thaker, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

miRNA profile and advanced stage endometrial cancer

C. Croce, Chang-gong Liu, C. Taccioli, 2008 .

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies

S. Waggoner, C. Kunos, R. Debernardo, 2012, Front. Oncol..

Surgery: Role of lymphadenectomy in the staging of endometrial cancer

D. Cohn, J. Fowler, K. Resnick, 2009, Nature Reviews Clinical Oncology.

Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer.

C. Morrison, W. Frankel, D. Cohn, 2010, Gynecologic oncology.

An unusual presentation of a urethral diverticulum as a vaginal wall mass: a case report

A. Hijaz, K. Resnick, M. Billow, 2013, Journal of Medical Case Reports.

Improved Survival With an Intact DNA Mismatch Repair System in Endometrial Cancer

C. Morrison, W. Frankel, H. Hampel, 2006, Obstetrics and gynecology.

Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment

A. Difeo, S. Waggoner, QuanQiu Wang, 2017, Oncogene.

Fertility-sparing management of a stage IB1 small cell neuroendocrine cervical carcinoma with radical abdominal trachelectomy and adjuvant chemotherapy

R. Redline, K. Resnick, Sareena Singh, 2015, Gynecologic oncology reports.

Advanced endometrial cancer with serous metastasis in a 17-year-old.

C. Morrison, N. Ramirez, D. Cohn, 2006, Gynecologic oncology.

A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

S. Howell, H. Lankes, P. Rose, 2012, Gynecologic oncology.

Longer operative time is associated with increased post-operative complications in patients undergoing minimally-invasive surgery for endometrial cancer.

K. Resnick, Sareena Singh, K. Swarer, 2017, Gynecologic oncology.

Preoperative frailty is a risk factor for non-home discharge in patients undergoing surgery for endometrial cancer.

K. Resnick, Sareena Singh, P. Adedayo, 2018, Journal of geriatric oncology.